CVE-2024-29421

CVE-2024-29421 is a medium-severity vulnerability with a CVSS 3.x base score of 6.2. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-121.

Key facts

Description

xmedcon 0.23.0 and fixed in v.0.24.0 is vulnerable to Buffer Overflow via libs/dicom/basic.c which allows an attacker to execute arbitrary code.

Frequently asked questions

What is CVE-2024-29421?
xmedcon 0.23.0 and fixed in v.0.24.0 is vulnerable to Buffer Overflow via libs/dicom/basic.c which allows an attacker to execute arbitrary code.
How severe is CVE-2024-29421?
CVE-2024-29421 has a CVSS 3.x base score of 6.2, rated medium severity. It is exploitable over local access with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is none, integrity none, and availability high.
Is CVE-2024-29421 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (16th percentile), an estimate of the probability of exploitation in the next 30 days.
How do I fix CVE-2024-29421?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2024-29421 have an EU (EUVD) identifier?
Yes. CVE-2024-29421 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-26427.
When was CVE-2024-29421 published?
CVE-2024-29421 was published on 2024-05-22 and last updated on 2026-06-17.

References

Other CWE-121 (Stack-based Buffer Overflow) vulnerabilities

Browse all CWE-121 (Stack-based Buffer Overflow) vulnerabilities →